Nurix Therapeutics, Inc. NRIX Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s change in lease liabilities?
- Nurix Therapeutics, Inc. (NRIX) reported change in lease liabilities of $205K in Q4 2025.
- How has Nurix Therapeutics, Inc.'s change in lease liabilities changed year-over-year?
- Nurix Therapeutics, Inc.'s change in lease liabilities increased by 112.2% year-over-year, from -$1.68M to $205K.
- What is the long-term trend for Nurix Therapeutics, Inc.'s change in lease liabilities?
- Over 4 years (2021 to 2025), Nurix Therapeutics, Inc.'s change in lease liabilities has grown at a -0.4% compound annual growth rate (CAGR), from -$5.14M to -$5.07M.
- What does change in lease liabilities mean?
- Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.